Fed Circuit Watch: Another Mayo, Another §101 Kill
Medical diagnostics patents involving a certain lab testing company named Mayo took a hit when those patents were deemed invalid under 35 U.S.C. §101. No, it’s not that Mayo case, but the one in...
Medical diagnostics patents involving a certain lab testing company named Mayo took a hit when those patents were deemed invalid under 35 U.S.C. §101. No, it’s not that Mayo case, but the one in...
Mobile World Congress opens in Barcelona, Spain, on February 25-28, 2019. To commemorate the mobile industry’s largest trade show, this blog will showcase various recently issued U.S. patents...
Mobile World Congress opens in Barcelona, Spain, on February 25-28, 2019. To commemorate the mobile industry’s largest trade show, this blog will showcase various recently issued U.S. patents...
U.S. Patent No. 10,039,740 B2 (‘740) issued on August 7, 2018, for “Therapeutic Combinations of Sesquiterpenes and Flavonoids.” It was issued to inventor Masayoshi Yamaguchi of Shizuoka, Japan. The...
U.S. Patent No. PP29,981 P2 (‘981) issued on December 11, 2018, for “Heuchera Plant Named “Orange Dream’.” It was issued to inventor/applicant Thierry Delabroye of Hantay, France. The assignee is...
U.S. Patent No. 10,123,538 B2 (‘538), issued on November 13, 2018, for “Glyphosate Salt Herbicidal Composition.” The inventors are David R. Eaton of Kirkwood, Missouri, Jeffrey A. Graham of...
U.S. Patent No. PP29,967 P2 (‘967) issued on December 11, 2018, for “Strawberry Plant Named ‘Malibu’.” It was issued to inventor/applicant John Larse of Watsonville, California. The assignee is...
Two cases decided recently by the Court of Appeals for the Federal Circuit discuss the oft-problematic area of 35 U.S.C. §103, or the nonobviousness requirement. This is the second case, Realtime...
On January 22, 2019, the United States Supreme Court handed down a highly anticipated ruling that has caused measurable discrepancies amongst the patent community after the America Invents Act (AIA)...
Two cases decided recently by the Court of Appeals for the Federal Circuit discuss the oft-problematic area of 35 U.S.C. §103, or the nonobviousness requirement. AC Technologies S.A. v. Amazon.com,...